Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8953)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2021 (publication date) through Apr 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gangadharan C, Ahluwalia R, Sigamani A. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity . World J Diabetes 2021; 12(9): 1550-1562 [PMID: 34630907 DOI: 10.4239/wjd.v12.i9.1550] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v12/i9/1550.htm |
| Number | Citing Articles |
| 1 |
Daniel Gonikman, Dmitrijs Kustovs. Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic. Medicina 2023; 59(10): 1810 doi: 10.3390/medicina59101810
|
| 2 |
Ivette Emery, Clifford Rosen. Adult Long Coronavirus Disease 2019. Infectious Disease Clinics of North America 2025; doi: 10.1016/j.idc.2025.02.007
|
| 3 |
Ricardo Wesley Alberca, Yasmim Álefe Leuzzi Ramos, Nátalli Zanete Pereira, Danielle Rosa Beserra, Anna Cláudia Calvielli Castelo Branco, Raquel Leão Orfali, Valeria Aoki, Alberto Jose da Silva Duarte, Maria Notomi Sato. Long-term effects of COVID-19 in diabetic and non-diabetic patients. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.963834
|
| 4 |
Tushar Sood, Nicolas Perrot, Michael Chong, Pedrum Mohammadi-Shemirani, Maha Mushtaha, Darryl Leong, Sumathy Rangarajan, Sibylle Hess, Salim Yusuf, Hertzel C. Gerstein, Guillaume Paré, Marie Pigeyre. Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk. JAMA Network Open 2023; 6(7): e2325914 doi: 10.1001/jamanetworkopen.2023.25914
|
| 5 |
Mariangela Caporusso, Sebastio Perrini, Francesco Giorgino, Luigi Laviola. Implicazioni cliniche extraglicemiche dell’insulino-resistenza. L'Endocrinologo 2022; 23(4): 380 doi: 10.1007/s40619-022-01131-3
|
| 6 |
Alef Aragão Carneiro dos Santos, Luiz Eduardo Rodrigues, Amanda Lins Alecrim-Zeza, Liliane de Araújo Ferreira, Caio dos Santos Trettel, Gabriela Mandú Gimenes, Adelson Fernandes da Silva, Celso Pereira Batista Sousa-Filho, Tamires Duarte Afonso Serdan, Adriana Cristina Levada-Pires, Elaine Hatanaka, Fernanda Teixeira Borges, Marcelo Paes de Barros, Maria Fernanda Cury-Boaventura, Gisele Lopes Bertolini, Priscila Cassolla, Gabriel Nasri Marzuca-Nassr, Kaio Fernando Vitzel, Tania Cristina Pithon-Curi, Laureane Nunes Masi, Rui Curi, Renata Gorjao, Sandro Massao Hirabara. Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1037467
|
| 7 |
Yichi Zhang, Zhuchao Wu, Xiaona Li, Jingkai Wei, Qun Zhang, Jianming Wang. Association between the triglyceride-glucose index and carotid plaque incidence: a longitudinal study. Cardiovascular Diabetology 2022; 21(1) doi: 10.1186/s12933-022-01683-6
|
| 8 |
Esmaeil Mehraeen, Faeze Abbaspour, Maciej Banach, SeyedAhmad SeyedAlinaghi, Ameneh Zarebidoki, Seyed Saeed Tamehri Zadeh. The prognostic significance of insulin resistance in COVID-19: a review. Journal of Diabetes & Metabolic Disorders 2024; 23(1): 305 doi: 10.1007/s40200-024-01385-8
|
| 9 |
Viktoria Pai, Andrea Bileck, Nikolaus Hommer, Patrick Janku, Theresa Lindner, Victoria Kauer, Benedikt Rumpf, Helmuth Haslacher, Gerhard Hagn, Samuel M. Meier-Menches, Leopold Schmetterer, Doreen Schmidl, Christopher Gerner, Gerhard Garhöfer. Impaired retinal oxygen metabolism and perfusion are accompanied by plasma protein and lipid alterations in recovered COVID-19 patients. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56834-4
|
| 10 |
E. Cure, M. Cumhur Cure. Insulin may increase disease severity and mortality of COVID-19 through Na+/H+ exchanger in patients with type 1 and type 2 diabetes mellitus. Journal of Endocrinological Investigation 2022; 46(4): 845 doi: 10.1007/s40618-022-01951-y
|
| 11 |
Cecilia C. Low Wang, Stacey A. Seggelke, Michael T. McDermott, Jane E. B. Reusch. Diabetes and COVID-19. Contemporary Endocrinology 2023; : 19 doi: 10.1007/978-3-031-28536-3_2
|
| 12 |
Tuncay Tuluk, Teoman Kankılıç, İlkay Civelek, Dilara Fatma Akın, Mehmet Bankır. Genomic profiling of interferon signaling pathway gene mutations in type 2 diabetic individuals with COVID-19. Turkish Journal of Biochemistry 2025; 50(1): 80 doi: 10.1515/tjb-2024-0139
|
| 13 |
Yufen Zheng, Jing Wang, Xianhong Ding, Shiyong Chen, Jun Li, Bo Shen. The Correlation Between Triglyceride-Glucose Index and SARS-CoV-2 RNA Re-Positive in Discharged COVID-19 Patients. Infection and Drug Resistance 2022; : 3815 doi: 10.2147/IDR.S368568
|
| 14 |
Jędrzej Warpechowski, Paula Leszczyńska, Dominika Juchnicka, Adam Olichwier, Łukasz Szczerbiński, Adam Jacek Krętowski. Assessment of the Immune Response in Patients with Insulin Resistance, Obesity, and Diabetes to COVID-19 Vaccination. Vaccines 2023; 11(7): 1203 doi: 10.3390/vaccines11071203
|
| 15 |
Emi Ushigome, Dan Imai, Masahide Hamaguchi, Satoru Hashimoto, Michiaki Fukui. Maximum insulin dose in patients admitted to the intensive care units with severe COVID‐19 in the “Cross ICU Searchable Information System” study: A multicenter retrospective cohort study. Journal of Diabetes Investigation 2025; 16(3): 555 doi: 10.1111/jdi.14380
|
| 16 |
Yoonkyung Chang, Jimin Jeon, Tae-Jin Song, Jinkwon Kim. Association of triglyceride-glucose index with prognosis of COVID-19: A population-based study. Journal of Infection and Public Health 2022; 15(8): 837 doi: 10.1016/j.jiph.2022.06.014
|
| 17 |
Naina Mohamed Pakkir Maideen, Rajkapoor Balasubramanian, Mirunalini Gobinath, Mohamed Rafiullah, Sudha Muthusamy. Therapeutic Potentials of Black Seeds (Nigella sativa) in the Management of COVID-19 -A Review of Clinical and In-silico Studies. Anti-Infective Agents 2023; 21(1): 14 doi: 10.2174/2211352520666220802150156
|
| 18 |
Xiao-Peng Qu, Ying-Le Wu, Liang-Liang Shen, Chao Wang, Li Gao, Jia-Qi Ma, Yan Qu, Bei Liu. Utility of the triglyceride-glucose index for predicting restenosis following revascularization surgery for extracranial carotid artery stenosis: A retrospective cohort study. Journal of Stroke and Cerebrovascular Diseases 2024; 33(3): 107563 doi: 10.1016/j.jstrokecerebrovasdis.2024.107563
|
| 19 |
Irina A. Komarevtseva, Kateryna V. Balabanova, Anna Yu. Ihnatova, Vitaliy N. Komarevtsev, Andriy I. Burachyk, Oleksandr A. Zhurba, Yuri A. Chernykh. The severity and outcome of Covid-19 depend on the various activities of the renin-angiotensin-aldosterone system, level of the opioid growth factor, [met5]-enkephalin and pre-existing comorbidities. Polski Merkuriusz Lekarski 2024; 52(5): 562 doi: 10.36740/Merkur202405113
|
| 20 |
Ana L Peralta Amaro, Julio C Ramírez Ventura, Luis R Bañuelos García, Emily I Pecero García, José G Valadez Calderón, Rosa N Hernández Flandes. Importance of Insulin Resistance in the COVID-19 Era: A Retrospective Analysis of a Single Center in Mexico. Cureus 2022; doi: 10.7759/cureus.29542
|
| 21 |
Praise Tatenda Nhau, Mlindeli Gamede, Ntethelelo Sibiya. COVID-19-Induced Diabetes Mellitus: Comprehensive Cellular and Molecular Mechanistic Insights. Pathophysiology 2024; 31(2): 197 doi: 10.3390/pathophysiology31020016
|
| 22 |
Hiba S Ahmed, Haylim N Abud, Hind S Ahmed. State of type 2 diabetic Iraqi patients after hospitalization for COVID-19. Human Antibodies 2025; doi: 10.1177/10932607241304947
|
| 23 |
Premranjan Kumar, Ob Osahon, David B. Vides, Nicola Hanania, Charles G. Minard, Rajagopal V. Sekhar. Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation. Antioxidants 2021; 11(1): 50 doi: 10.3390/antiox11010050
|
| 24 |
Takaaki Matsui, Emi Ushigome, Masahide Hamaguchi, Kazuki Sudo, Nobuko Kitagawa, Yuriko Kondo, Yuka Hasegawa, Dan Imai, Tomohiro Hattori, Masahiro Yamazaki, Teiji Sawa, Michiaki Fukui. Increased Insulin Requirements in Severe Cases of Covid-19 are Higher Than in Moderate Cases. Diabetes, Metabolic Syndrome and Obesity 2024; : 3727 doi: 10.2147/DMSO.S480598
|